KALVISTA PHARMACEUTICALS INC (KALV) Institutional Ownership Changes & 13F Activity
KALVISTA PHARMACEUTICALS INC (KALV). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Millennium Management Llc, Driehaus Capital Management Llc, Armistice Capital, Llc, Catalio Capital Management, Lp, and Woodline Partners Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Mirae Asset Global Investments Co., Ltd. | Buy | +180 | +7.3% | 2,636 | $53.06K | Q1 2026 | Aug 12, 2026 |
| Algert Global Llc | Sell | -13,110 | -100.0% | 0 | $0.00 | Q1 2026 | Aug 11, 2026 |
| Wells Fargo & Company/Mn | Sell | -32,087 | -57.3% | 23,927 | $481.65K | Q1 2026 | Jul 08, 2026 |
| Bank Of America Corp | Buy | +165,815 | +42.5% | 555,628 | $11.18M | Q1 2026 | May 18, 2026 |
| California State Teachers Retirement System | Sell | -12,968 | -45.6% | 15,442 | $310.85K | Q1 2026 | May 18, 2026 |
| Millennium Management Llc | Sell | -984,520 | -34.0% | 1,912,146 | $38.49M | Q1 2026 | May 15, 2026 |
| Driehaus Capital Management Llc | Buy | +564,039 | — | 564,039 | $11.35M | Q1 2026 | May 15, 2026 |
| Armistice Capital, Llc | Buy | +436,000 | +54.5% | 1,236,000 | $24.88M | Q1 2026 | May 15, 2026 |
| Catalio Capital Management, Lp | Buy | +426,551 | — | 426,551 | $8.59M | Q1 2026 | May 15, 2026 |
| Woodline Partners Lp | Sell | -411,172 | -21.4% | 1,509,920 | $30.39M | Q1 2026 | May 15, 2026 |
| Orbimed Advisors Llc | Sell | -288,000 | -75.3% | 94,400 | $1.90M | Q1 2026 | May 15, 2026 |
| Squadron Capital Management Llc | Buy | +285,100 | +40.7% | 985,100 | $19.83M | Q1 2026 | May 15, 2026 |
| Ishara Investments Lp | Buy | +276,750 | — | 276,750 | $5.57M | Q1 2026 | May 15, 2026 |
| Morgan Stanley | Sell | -261,129 | -37.3% | 439,099 | $8.84M | Q1 2026 | May 15, 2026 |
| Venrock Adviser, Llc | Sell | -254,500 | -3.8% | 6,474,485 | $130.33M | Q1 2026 | May 15, 2026 |
| Freestone Grove Partners Lp | Buy | +249,887 | +39.5% | 882,906 | $17.77M | Q1 2026 | May 15, 2026 |
| Elmind Capital, Lp | Buy | +220,000 | +27.5% | 1,021,300 | $20.56M | Q1 2026 | May 15, 2026 |
| Qube Research & Technologies Ltd | Buy | +180,314 | — | 180,314 | $3.63M | Q1 2026 | May 15, 2026 |
| Octagon Capital Advisors Lp | Buy | +176,667 | +13.9% | 1,450,000 | $29.19M | Q1 2026 | May 15, 2026 |
| Barclays Plc | Sell | -163,512 | -23.3% | 537,061 | $10.81M | Q1 2026 | May 15, 2026 |
| Marshall Wace, Llp | Buy | +162,908 | — | 162,908 | $3.28M | Q1 2026 | May 15, 2026 |
| Two Sigma Investments, Lp | Buy | +153,459 | — | 153,459 | $3.09M | Q1 2026 | May 15, 2026 |
| Point72 Asset Management, L.P. | Sell | -146,826 | -6.4% | 2,136,940 | $43.02M | Q1 2026 | May 15, 2026 |
| Squarepoint Ops Llc | Buy | +143,966 | — | 143,966 | $2.90M | Q1 2026 | May 15, 2026 |
| Trexquant Investment Lp | Buy | +139,458 | — | 139,458 | $2.81M | Q1 2026 | May 15, 2026 |
| Dafna Capital Management Llc | Sell | -89,400 | -25.1% | 267,402 | $5.38M | Q1 2026 | May 15, 2026 |
| Seven Fleet Capital Management Lp | Buy | +80,075 | +165.4% | 128,487 | $2.59M | Q1 2026 | May 15, 2026 |
| Frazier Life Sciences Management, L.P. | Sell | -78,759 | -1.6% | 4,961,108 | $99.87M | Q1 2026 | May 15, 2026 |
| Fmr Llc | Buy | +76,041 | +68.0% | 187,848 | $3.78M | Q1 2026 | May 15, 2026 |
| Parkman Healthcare Partners Llc | Buy | +66,998 | +3.8% | 1,835,506 | $36.95M | Q1 2026 | May 15, 2026 |
Frequently asked questions about KALV activity
Which institutional owners are buying KALV?
Institutional owners buying KALV include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in KALV activity?
"Buy" means an investor increased their reported position in KALV compared to the prior reporting period. This reflects growing exposure to KALVISTA PHARMACEUTICALS INC (KALV) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in KALV increasing?
Institutional interest in KALV can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related KALV Institutional Insights
- KALV Overview
- KALV 13F Institutional Holders
- KALV Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- KALV Insider Trading & SEC Form 4 Activity
- KALV Articles
- Top Institutional Investor Stock Rankings